Can SLC19A1 80G>A polymorphisms predict risk of extremely delayed MTX excretion after high dose of methotrexate?

J Pediatr Hematol Oncol. 2013 Jul;35(5):417-8. doi: 10.1097/MPH.0b013e318290c11c.
No abstract available

Publication types

  • Letter

MeSH terms

  • Child
  • Genotype
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / metabolism*
  • Polymorphism, Single Nucleotide
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Reduced Folate Carrier Protein / genetics*

Substances

  • Reduced Folate Carrier Protein
  • SLC19A1 protein, human
  • Methotrexate